AI-assisted single-session radiotherapy after breast-conserving surgery
Part of Cancer clinical trials.
This trial tests a new approach where all radiation is given in one session using AI guidance. It is for women who had breast-conserving surgery with lymph node removal and need radiation afterward.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 70
- You had breast-conserving surgery with lymph nodes removed and cancer cells were found in those nodes
- Your cancer has not spread to other parts of the body
- You can lie still on a treatment bed for about 30 minutes
- You are willing to take hormone therapy for 5 years if your cancer is hormone-sensitive, or anti-HER2 therapy for 1 year if your cancer is HER2-positive
- You have not had chest radiation before or another active cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a faster, all-in-one radiation therapy approach for breast cancer using a CT-Linac machine. It aims to make treatment more convenient and may be an option if you need radiation before, after, or instead of surgery.
This trial tests a new, shorter radiation treatment given all at once after breast-conserving surgery for early-stage breast cancer. It is for people with small tumors that have not spread far, and aims to reduce side effects and visits to the clinic.
This trial tests a new way to deliver radiation therapy that adapts to each patient's body changes during treatment. It is for women who had breast cancer surgery and need radiation to the whole breast and nearby lymph nodes, and who have been identified as being at risk for breast fibrosis.
This Phase 3 study tests a specific plan that combines chemotherapy (and sometimes targeted medicines) with radiation before surgery for one breast. It may help shrink breast cancer and improve treatment timing, based on how well tumors respond.
This trial studies whether some patients with early-stage breast cancer can safely skip a specific part of radiation to the inner chest (called internal mammary irradiation). It may reduce radiation side effects while still aiming to prevent the cancer from coming back.
This trial is testing a new treatment approach for patients with a certain type of breast cancer (HR+/HER2-). It combines radiation therapy with chemotherapy and an immunotherapy drug before the patient's main surgery, to see if it can shrink or eliminate the tumor more effectively.
Hear when a new Breast Cancer Invasive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.